Formed in 2005, Dexela is a developer of technologies for fast, low-dose X-ray imaging.
The company initially pioneered developments in breast tomosynthesis, an advanced imaging technique focused on the early detection of breast cancer.
In 2009, Dexela launched a family of flat-panel CMOS X-ray detectors for applications including mammography, fluoroscopy, dental CT, cardiology and non-destructive testing. These products have subsequently been exported to OEMs around the world, including Europe, the US, Korea and China.
Albion invested a total of £2.6m in Dexela, initially as lead investor in 2006. Albion and LTF then led a syndicate (including NESTA), that invested more than £3m between July 2008 and January 2009 to further exploit the growing number of commercial opportunities within the digital-imaging market.
‘At a time when UK start-ups are in need of public and private funding this is a superb example of how venture capital backing can help UK small business and it is encouraging that UK talent is attractive to a US S&P 500 company such as this,’ said Andrew Elder, partner, Albion Ventures.
Glasgow trial explores AR cues for autonomous road safety
They've ploughed into a few vulnerable road users in the past. Making that less likely will make it spectacularly easy to stop the traffic for...